09 January 2013: Clinical Research
Ratio of Angiopoietin-2 to Angiopoietin-1 predicts mortality in acute lung injury induced by paraquat
Jae-Sung Choi AEF , Kyung-A Kwak B , Min-Ju Park B , Young-Hee Kim CD , Hyo-Wook Gil ADFG , Ho-yeon Song DF , Sae-yong Hong DFG
DOI: 10.12659/MSM.883730
Med Sci Monit 2013; 19:28-33
Background
Endothelial injury has been studied in septic and non-septic patients, both at risk for and with established acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) [1]. Several clinical studies have demonstrated that circulating levels of angiopoietin-2 (Ang-2), which are associated with mortality, are elevated at the onset of critical illness or in those at risk for ALI/ARDS. This relates to vascular permeability and pulmonary dysfunction [2–12]. Experimental studies have demonstrated that angiopoietin-1 (Ang-1) and Ang-2 bind to endothelial tyrosine kinase with immunoglobulin and epidermal growth factor homology domains 2 receptor (Tie2 receptor) [13]. Ang-1-induced activation of the Tie2 receptor results in vascular stabilization [14–16]. Ang-2 provokes pulmonary inflammation and vascular leakage, partly by preventing Ang-1 from binding the Tie2 receptor, thereby inhibiting the stabilizing effect of Ang-1 [16,17]. This suggests that Ang-2 is not only a marker but also a direct mediator in the pathogenesis of vascular permeability and pulmonary injury and dysfunction in septic and non-septic patients [18–20]. Furthermore, the ratio of Ang-2 concentration to Ang-1 concentration may be a prognostic biomarker of endothelial activation in ALI patients [10]. The antigen von Willebrand factor (VWF) is a macromolecular antigen that is produced predominantly by endothelial cells and in lesser amounts by platelets. VWF is a large multimeric glycoprotein present in blood plasma and produced constitutively in Weibel-Palade bodies, megakaryocytes (α-granules of platelets), and subendothelial connective tissue [21]. VWF is not related to vascular permeability, but instead reflects endothelial damage. Some studies have shown that VWF is a marker of poor outcome in patients with ALI/ARDS [12,22,23].
Paraquat (1,1-dimethyl-4-4-bipyridium dichloride; PQ) is used not only as an herbicide but also to produce reactive oxygen species (ROS) in the oxidative stress model [24]. Paraquat mainly accumulates in the lungs, where it is retained even when its concentration in the blood starts to decrease. Subsequent redox cycling and generation of ROS trigger lung injury. ROS play a crucial role in the pathogenesis of various lung diseases such as asthma, chronic obstructive pulmonary disease, and acute respiratory distress syndrome. Paraquat-induced lung injury might be a unique model of dominant ROS-induced lung injury [25,26]. ROS can lead to endothelial barrier dysfunction with subsequent increased permeability to fluid, macromolecules, and inflammatory cells. We hypothesized that endothelial cell injury could be involved in early death after paraquat intoxication and that concentrations of Ang-1, Ang-2, and VWF could reflect endothelial cell injury.
The aim of our study was to investigate whether Ang-2, VWF, and Ang-1 are related to early mortality. Therefore, we measured initial plasma levels of these markers in patients who intentionally ingested paraquat.
Material and Methods
STATISTICAL ANALYSIS:
Data are presented as means ±SD for continuous variables and frequencies (percentages) for categorical variables. Differences between groups were evaluated with Student’s
Results
Characteristics of the 60 patients with acute paraquat poisoning at the time of their arrival are summarized in Table 1. Their mean age was 51.75±17.89 years, and 36 (60%) were men. The mean estimated amount of ingested paraquat dichloride was 83.89 mL (range, 5–500 mL). Overall mortality was 63.3%. Paraquat concentrations in blood ranged from 0.02 to 618.66 μg/mL. Mean Ang-1 level was 1.32±0.75 ng/mL. Mean Ang-2 level was 4.07±3.59 pg/mL. Mean VWF was 15.09±10.85 mU/mL. Mean Ang-2: Ang-1 ratio was 4.24±4.82.
Comparisons of Ang-1, Ang-2, Ang-2: Ang-1 ratio, and VWF between survivors and non-survivors are shown in Table 2. Although the 2 groups had no statistically significant difference in Ang-1, the Ang-2 and Ang-2: Ang-1 ratio were significantly higher in non-survivors than in survivors.
HRCT was done for 30 patients (22 survivors and 8 non-survivors). Mild lung lesion was found in 21 patients and severe lung lesion in 9 patients. According to HRCT, the 2 groups had no statistically significant difference in Ang-1, Ang-2, Ang-2: Ang-1 ratio, or VWF (not shown data).
Serial change of Ang-1, Ang-2, and Ang-2: Ang-1 ratio in 3 patients is shown in Figure 1. The Ang-2: Ang-1 ratio peaked within 1 day after paraquat ingestion, and then the level of the ratio decreased.
The patients were grouped into 3 categories: survivors, early death group (died within 5 days after ingestion), and late death group (died more than 5 days after ingestion). The Ang-2: Ang-1 ratio and plasma paraquat level were significantly higher in the early death group than in the others (Table 2). In addition, the pCO2 and HCO3– (mEq/L) were lower in this group.
Univariate analysis showed a statistically significant association between baseline plasma Ang-2 level and death (OR, 1.001; 95% CI, 1.000–1.002; p=0.017). Moreover, Ang-2: Ang-1 ratio was significantly associated with death (OR, 1.928; 95% CI, 1.116–3.331; p=0.019), as was plasma paraquat level (OR, 1.078; 95% CI, 1.052–1.137; p=0.006). Ang-1 (OR, 1; 95% CI, 0.999–1.001; p=0.326) and VWF (OR, 1.045; 95% CI, 0.993–1.100; p=0.091) were not associated with death.
In multivariate analysis, Ang-2: Ang-1 ratio was significantly associated with early death after adjustment for several combinations of potential confounders: plasma levels of paraquat (OR, 2.644; 95% CI, 1.206–5.795; p=0.015); plasma levels of paraquat, and age (OR, 2.906; 95% CI, 1.297–6.512; p=0.010); plasma levels of paraquat, age, and PCO2 (OR, 2.644; 95% CI, 1.173–5.960; p=0.019); and plasma levels of paraquat, age, PCO2, and creatinine (OR, 2.602; 95% CI, 1.106–6.117; p=0.028).
Discussion
ALI induced by paraquat causes progressive pulmonary insufficiency. The toxicity of paraquat is due to its induction of redox cycling, which leads to oxidative stress-related cell death and inflammation. Because of selective accumulation in the lungs, especially in type II pneumocytes, paraquat causes severe lung injury manifested by edema, hemorrhage, interstitial inflammation, and progressive fibrosis [24,28].
The severity of paraquat ingestion poisoning can be classified into 3 categories [29]. First, patients who ingest less than 20 mg paraquat cation per kilogram of body weight may be asymptomatic or develop only gastrointestinal tract symptoms; they recover without sequelae. Second, patients who ingest between 20 and 40 mg paraquat cation per kilogram usually die 5 days to several weeks after ingestion. The cause of death is progressive development of pulmonary fibrosis. Third, patients who ingest more than 40 mg paraquat cation per kilogram usually die within 1–5 days after ingestion, mainly because of multiorgan failure or shock.
We investigated whether initial endothelial cell injury could involve the ROS-induced injury model. We suspected that the cause of death in the early death group might be multiorgan failure due to endothelial cell injury.
Ang-2: Ang-1 ratio and Ang-2 were higher in the early death group than in the other groups. These findings suggest that endothelial cell damage may have been involved in the pathogenesis resulting from paraquat intoxication in the early death group.
Although it has previously been suggested that endothelial cell damage occurs after paraquat poisoning, the underlying mechanism has not been revealed. Some data showed that paraquat directly induced cytotoxicity in pulmonary microvascular endothelial cells [28]. Furthermore, lung inflammation indirectly induced by paraquat could evoke endothelial damage. Paraquat could cause an increase in vascular permeability that is attributed to endothelial cell injury. Our study showed that the Ang-2: Ang-1 ratio can predict mortality.
Some acute injury markers can predict mortality in cases of ALI/ARDS. Among these markers, Ang-2, Ang-2: Ang-1 ratio, and VWF can induce endothelial cell injury, which increases vascular permeability. Ang-2, Ang-2: Ang-1 ratio, and VWF may be good markers to predict mortality in sepsis models and septic patients [2,6,8–12]. Increased vascular permeability is the key mechanism in the pathogenesis of sepsis-induced lung injury. Therefore, initial endothelial cell injury markers could explain death in these models.
Paraquat-induced lung injury may be a good model for representing ROS-induced lung injury [25,26]. The main target cells are type II alveolar cells because of the accumulation of paraquat. The paraquat-induced lung injury model might be different from the lipopolysaccharide model, because ROS-induced cell toxicity is a major mechanism in the paraquat model.
We showed that Ang-2: Ang-1 ratio can predict early mortality in multivariate analysis.
Ang-2 is proinflammatory and promotes vascular permeability. In contrast, Ang-1 stabilizes the endothelium. The Ang-2: Ang-1 ratio may reflect endothelial cell injury in the pulmonary microvasculature, which suggests that this mechanism could be involved in early damage to the pulmonary microvasculature and increased vascular permeability to paraquat.
VWF did not predict mortality in patients with paraquat poisoning. The use of VWF to predict ALD/ARDS in other situations has been controversial [12,23,30]. A study on poisoned patient sample time might be important because of the different dose and time interval after poisoning. Sabharwal et al showed that sequential plasma samples obtained from patients with ARDS had progressively increasing levels of VWF, up to days 4 and 8 [31]. Caflee et al showed that VWF did not have differential prognostic value for mortality depending on the presence or absence of infection as a risk factor for ALI, but Ang-2 is a prognostic marker [19]. Indeed, further basic study is needed to understand when and how paraquat injures the pulmonary microvascular system.
The serial change of Ang-1, Ang-2, and Ang-2: Ang-1 ratio is shown in Figure 1. The Ang-2: Ang-1 ratio peaked within 1 day. We thought that paraquat-initiated endothelial injury might be associated with an early mechanism of pathogenesis and sequentially trigger inflammation and fibrosis.
According to HRCT, Ang-2: Ang-1 ratio does not reflect lung damage. Early death patients were excluded from this analysis because HRCT was performed 7 days after ingestion; this could be selection bias. ROS-directed lung injury may have been the principle pathogenic mechanism in the patients who underwent HRCT. Thus, according to HRCT, the endothelial damage marker was not different.
Our study had some limitations. First, we measured the sequential change of these markers in only 3 patients. Second, the origin of Ang-2 and Ang-1 was unknown. Regardless of origin, the Ang-2: Ang-1 ratio might reflect the endothelial damage that occurs after paraquat intoxication.
Conclusions
In conclusion, endothelial cell damage could play a role in pathogenesis leading to early death after paraquat ingestion.
References
1. Pittet J, Mackersie R, Martin T, Biological markers of acute lung injury: prognostic and pathogenetic significance: Am J Respir Crit Care Med, 1997; 155(4); 1187-205, pmid: 9105054
2. Giuliano JS, Lahni PM, Harmon K, Admission angiopoietin levels in children with septic shock: Shock, 2007; 28(6); 650-54, pmid: 18092380
3. Orfanos SE, Kotanidou A, Glynos C, Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators: Crit Care Med, 2007; 35(1); 199-206, pmid: 17110873
4. Gallagher DC, Parikh SM, Balonov K, Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome: Shock, 2008; 29(6); 656-61, pmid: 18091573
5. Ganter MT, Cohen MJ, Brohi K, Angiopoietin-2, marker and mediator of endothelial activation with prognostic significance early after trauma?: Ann Surg, 2008; 247(2); 320-26, pmid: 18216540
6. Giamarellos-Bourboulis EJ, Kanellakopoulou K, Pelekanou A, Kinetics of angiopoietin-2 in serum of multi-trauma patients: correlation with patient severity: Cytokine, 2008; 44(2); 310-13, pmid: 18952457
7. Kumpers P, Lukasz A, David S, Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients: Crit Care, 2008; 12(6); R147, pmid: 19025590
8. Siner JM, Bhandari V, Engle KM, Elevated serum angiopoietin 2 levels are associated with increased mortality in sepsis: Shock, 2009; 31(4); 348-53, pmid: 18791490
9. van der Heijden M, van Nieuw Amerongen GP, Koolwijk P, Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients: Thorax, 2008; 63(10); 903-9, pmid: 18559364
10. Ong T, McClintock DE, Kallet RH, Ratio of angiopoietin-2 to angiopoietin-1 as a predictor of mortality in acute lung injury patients: Crit Care Med, 2010; 38(9); 1845-51, pmid: 20581666
11. Ricciuto DR, Dos Santos CC, Hawkes M, Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis: Crit Care Med, 2011; 39(4); 702-10, pmid: 21242795
12. Parikh SM, Mammoto T, Schultz A, Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans: PLoS Medicine, 2006; 3(3); 356-70
13. Eklund L, Olsen BR, Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling: Exp Cell Res, 2006; 312(5); 630-41, pmid: 16225862
14. Thurston G, Rudge JS, Ioffe E, Angiopoietin-1 protects the adult vasculature against plasma leakage: Nature medicine, 2000; 6(4); 460-63
15. Kwak HJ, Lee SJ, Lee YH, Angiopoietin-1 inhibits irradiation-and mannitol-induced apoptosis in endothelial cells: Circulation, 2000; 101(19); 2317-24, pmid: 10811601
16. Simoes D, Vassilakopoulos T, Toumpanakis D, Angiopoietin-1 protects against airway inflammation and hyperreactivity in asthma: Am J Respir Crit Care Med, 2008; 177; 1314-21, pmid: 18356565
17. Tabruyn S, Colton K, Morisada T, Angiopoietin-2-driven vascular remodeling in airway inflammation: Am J Pathol, 2010; 177; 3233-43, pmid: 20952594
18. Calfee CS, Gallagher D, Abbott Jthe NHLBI ARDS Network, Plasma angiopoietin-2 in clinical acute lung injury: Prognostic and pathogenetic significance: Crit Care Med, 2012; 40(6); 1731-37, pmid: 22610178
19. Koutsostathis S, Tsaganos T, Lallos S, Early increase of serum angiopoietin-2 are associated with early progression to death in experimental injury: Cytokine, 2011; 56(3); 817-22, pmid: 22024411
20. Bhandari V, Choo-Wing R, Harijith A, Increased hyperoxia-induced lung injury in nitric oxide synthase 2 null mice is mediated via angiopoietin 2: Am J Respir Cell Mol Biol, 2012; 46(5); 668-76, pmid: 22227562
21. Ribes JA, Francis CW, Wagner DD, Fibrin induces release of von Willebrand factor from endothelial cells: J Clin Invest, 1987; 79(1); 117-23, pmid: 3491837
22. Ware LB, Conner ER, Matthay MA, von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury: Crit Care Med, 2001; 29(12); 2325-31, pmid: 11801836
23. Ware LB, Eisner MD, Thompson BT, Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury: Am J Respir Crit Care Med, 2004; 170; 766-72, pmid: 15201135
24. Bus JS, Gibson JE, Paraquat: model for oxidant-initiated toxicity: Environ Health Perspect, 1984; 55; 37-46, pmid: 6329674
25. Delaval PM, Gillespie DJ, Pulmonary dysfunction during paraquat-induced lung injury: A model of acute alveolar injury: Crit Care Med, 1985; 13(12); 1056-60, pmid: 4064717
26. Webb D, Williams M, Davies B, Resolution after radiotherapy of severe pulmonary damage due to paraquat poisoning: Br Med J (Clin Res Ed), 1984; 288; 1259-60
27. Zou Y, Shi Y, Bai Y, An improved approach for extraction and high-performance liquid chromatography analysis of paraquat in human plasma: J Chromatogr B Analyt Technol Biomed Life Sci, 2011; 879(20); 1809-12
28. Rose MS, Smith LL, Wyatt I, Evidence for energy-dependent accumulation of paraquat into rat lung: Nature, 1974; 252; 314-15, pmid: 4431454
29. Vale J, Meredith T, Buckley B, Paraquat poisoning: clinical features and immediate general management: Hum Toxicol, 1987; 6(1); 41-47, pmid: 3546085
30. Moss M, Ackerson L, Gillespie MK, von Willebrand factor antigen levels are not predictive for the adult respiratory distress syndrome: Am J Respir Crit Care Med, 1995; 151; 15-20, pmid: 7812545
31. Sabharwal AK, Bajaj SP, Ameri A, Tissue factor pathway inhibitor and von Willebrand factor antigen levels in adult respiratory distress syndrome and in a primate model of sepsis: Am J Respir Crit Care Med, 1995; 151(3); 758-67, pmid: 7881667
In Press
Clinical Research
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...Med Sci Monit In Press; DOI: 10.12659/MSM.951027
Clinical Research
Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...Med Sci Monit In Press; DOI: 10.12659/MSM.950516
Review article
Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.951283
Clinical Research
Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.950938
Most Viewed Current Articles
17 Jan 2024 : Review article 10,187,196
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,708,487
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,341,643
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 706,524
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387






